116 related articles for article (PubMed ID: 1377101)
1. Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase.
Inouye Y; Tokutake Y; Kunihara J; Yoshida T; Yamase T; Nakata A; Nakamura S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):805-7. PubMed ID: 1377101
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity.
Inouye Y; Fujimoto Y; Sugiyama M; Yoshida T; Yamase T
Biol Pharm Bull; 1995 Jul; 18(7):996-1000. PubMed ID: 7581257
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of replication of human immunodeficiency virus by a heteropolyoxotungstate (PM-19).
Inouye Y; Take Y; Tokutake Y; Yoshida T; Yamamoto A; Yamase T; Nakamura S
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):285-7. PubMed ID: 2337949
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
5. Sulfonic acid polymers are potent inhibitors of HIV-1 induced cytopathogenicity and the reverse transcriptases of both HIV-1 and HIV-2.
Tan GT; Wickramasinghe A; Verma S; Hughes SH; Pezzuto JM; Baba M; Mohan P
Biochim Biophys Acta; 1993 Apr; 1181(2):183-8. PubMed ID: 7683207
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms of antiretroviral effects of HPA23.
Dormont D; Yeramian P; Lambert P; Spire B; Daveloose D; Barre-Sinoussi FC; Chermann JC
Cancer Detect Prev; 1988; 12(1-6):181-94. PubMed ID: 2460236
[TBL] [Abstract][Full Text] [Related]
7. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolyoxotungstates in vitro.
Take Y; Tokutake Y; Inouye Y; Yoshida T; Yamamoto A; Yamase T; Nakamura S
Antiviral Res; 1991 Feb; 15(2):113-24. PubMed ID: 1859202
[TBL] [Abstract][Full Text] [Related]
9. Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus.
Reimer K; Matthes E; Scholz D; Rosenthal HA
Acta Virol; 1989 Jan; 33(1):43-9. PubMed ID: 2469327
[TBL] [Abstract][Full Text] [Related]
10. Novel assay system favorable for the study of cell-to-cell transmission of HIV-1 and its application to the evaluation of anti-HIV drugs.
Inouye Y; Kanamori T; Fujimoto Y; Sugiyama M; Yoshida T
Biol Pharm Bull; 1995 Jun; 18(6):920-2. PubMed ID: 7550135
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23).
Ono K; Nakane H; Barré-Sinoussi F; Chermann JC
Eur J Biochem; 1988 Sep; 176(2):305-10. PubMed ID: 2458259
[TBL] [Abstract][Full Text] [Related]
12. Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.
Burgard M; Sansonetti P; Vittecoq D; Descamps P; Guetard D; Herson S; Rozenbaum W; Rouzioux C
AIDS; 1989 Oct; 3(10):665-8. PubMed ID: 2480798
[TBL] [Abstract][Full Text] [Related]
13. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptase.
Higuchi H; Mori K; Kato A; Ohkuma T; Endo T; Kaji H; Kaji A
Antiviral Res; 1991; 15(3):205-16. PubMed ID: 1716088
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and anti-human immunodeficiency virus activity of water-soluble salts of polyoxotungstate anions with covalently attached organic groups.
Weeks MS; Hill CL; Schinazi RF
J Med Chem; 1992 Apr; 35(7):1216-21. PubMed ID: 1373190
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.
Yusa K; Oh-hara T; Tsukahara S; Baba K; Taniguchi M; Kozawa M; Takeuchi S; Hara H; Tsuruo T
Antiviral Res; 1994 Sep; 25(1):57-66. PubMed ID: 7529015
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds.
Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D
Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226
[TBL] [Abstract][Full Text] [Related]
19. Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases.
Herve M; Sinoussi-Barre F; Chermann JC; Herve G; Jasmin C
Biochem Biophys Res Commun; 1983 Oct; 116(1):222-9. PubMed ID: 6196027
[TBL] [Abstract][Full Text] [Related]
20. Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates.
Shigeta S; Mori S; Kodama E; Kodama J; Takahashi K; Yamase T
Antiviral Res; 2003 May; 58(3):265-71. PubMed ID: 12767474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
